Company Profile
Avista Healthcare Partners is a leading private equity firm exclusively focused on investing in and growing healthcare companies. The firm targets growth-oriented businesses within the middle-market healthcare sector, leveraging its deep industry expertise, operational insights, and flexible capital solutions to drive growth and build lasting value. Avista has invested over $10 billion in more than 50 healthcare companies globally and has supported over 100 add-on acquisitions.
Founded in 2005 as a spin-out from DLJ Merchant Banking Partners, a renowned investment firm at the time, Avista Healthcare Partners was established by Thompson Dean, Steven Webster, and David Burgstahler. Initially a generalist investor, the firm strategically transitioned to an exclusive focus on the healthcare industry by 2013, recognizing the sector's dynamic opportunities and its team's extensive experience in healthcare products and technology.
The firm's portfolio includes notable investments across various healthcare subsectors. Past and present portfolio companies include Lantheus (medical imaging), ConvaTec (wound and ostomy care), Organogenesis (regenerative medicine), Cosette Pharmaceuticals (specialty pharmaceuticals), and Bentec Medical (complex silicone medical device components). Avista partners with businesses that exhibit strong management teams, stable cash flows, and robust growth prospects, particularly in areas like outsourced pharma and medtech services, consumer healthcare, medical devices, specialty and generic pharmaceuticals, distribution and diagnostics, and healthcare technology.
Avista Healthcare Partners boasts a highly experienced team, with its leadership having invested together in the healthcare sector for nearly three decades. The firm comprises 25 investment and operations professionals, complemented by 12 Healthcare Strategic Executives who provide crucial strategic insight, operational oversight, and senior counsel throughout the investment process. This collective expertise enables Avista to actively support management teams in driving organic growth, pursuing accretive acquisitions, and enhancing operational efficiencies.
News & Signals (0)
No linked news activity found for this company.